Skip to Main Content

Paper Details

A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy.
Leukemia
46
2021
Author NameAffiliation
Christoph R??lligMedical Clinic I, University Hospital Carl Gustav Carus
  • 1 - 1

Datasets

Release 1.2